Involving patient groups in the patient recruitment process is a strategy that might seem obvious, but is rarely adopted successfully. One of the issues is that patient groups can be wary of companies whom they may view as being only after their database of contacts in order to make money.

One way to get over this is to involve the patient groups right at the start of the process, during the trial design and protocol development stage. Showing a willingness to include the patient voice from the outset can help build a relationship that can be utilized once the trial launches and is looking for participants.

Providing information is another good way to engage with patient groups. Not necessarily about the condition itself, but maybe unique details about taking part in a trial or the way the treatment being tested was developed.

You may also like

Biotech C-suites Should keep Patient Recruitment in Mind from the Outset
In biotech, a strong C-suite isn’t just about job titles - it’s about covering every part of the journey from discovery to delivery. Including being prepared to tackle one of the biggest ...
Key C-suite Roles for Biotech Success - The Chief Patient Recruitment Officer (CPRO)
While biotech companies have built C-suites with scientific, medical, financial, operational, and business expertise, a critical function has remained conspicuously absent - addressing one ...
Key C-suite Roles for Biotech Success - The Chief Business Officer (CBO)
The Chief Business Officer leads external strategy - licensing deals, identifying pharma partnerships, and developing long-term growth planning and market positioning strategies that ...